{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:13:43Z","timestamp":1790313223678,"version":"4.1.0"},"reference-count":25,"publisher":"Impact Journals, LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,1,31]]},"DOI":"10.18632\/oncotarget.13503","type":"journal-article","created":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T21:53:32Z","timestamp":1479851612000},"page":"7533-7539","source":"Crossref","is-referenced-by-count":51,"title":["Silver nanoparticles enhance the sensitivity of temozolomide on human glioma cells"],"prefix":"10.18632","volume":"8","author":[{"given":"Ping","family":"Liang","sequence":"first","affiliation":[{"name":"Department of Neurology, Yancheng Hospital Affiliated to Southeast University, Yancheng, 224001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongming","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yancheng Hospital Affiliated to Southeast University, Yancheng, 224001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yancheng Hospital Affiliated to Southeast University, Yancheng, 224001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunfeng","family":"Gui","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yancheng Hospital Affiliated to Southeast University, Yancheng, 224001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yancheng Hospital Affiliated to Southeast University, Yancheng, 224001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yancheng Hospital Affiliated to Southeast University, Yancheng, 224001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Zhongda Hospital Affiliated to Southeast University, Nanjing, 210009, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First People's Hospital of Yancheng Affiliated to Nantong University, Yancheng, 224001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yancheng Hospital Affiliated to Southeast University, Yancheng, 224001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,11,22]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00130404-200305000-00003","article-title":"Current chemotherapy for glioblastoma","volume":"9","author":"Chang","year":"2003","journal-title":"Cancer"},{"key":"2","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(02)08091-1","article-title":"Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials","volume":"359","author":"Stewart","year":"2002","journal-title":"Lancet"},{"key":"3","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1073\/pnas.95.10.5724","article-title":"Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases","volume":"95","author":"Su Huang","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"4","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/cncr.24213","article-title":"Phase I pharmacokinetic study of the vascularendothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma","volume":"115","author":"Friedman","year":"2009","journal-title":"Cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Langer","year":"2007","journal-title":"Nat Nanotechnol"},{"key":"6","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s11095-006-0284-8","article-title":"Nanotechnology: intelligent design to treat complex disease","volume":"23","author":"Vauthier","year":"2006","journal-title":"Pharmacol Res"},{"key":"7","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd2614","article-title":"Nanoparticle therapeutics: an emerging treatment modality for cancer","volume":"7","author":"Shin","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"8","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.clpt.6100400","article-title":"Nanoparticles in medicine: therapeutic applications and developments","volume":"83","author":"Farokhzad","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1471-2121-10-65","article-title":"Anti-proliferative activity of silver nanoparticles","volume":"10","author":"Valiyaveettil","year":"2009","journal-title":"BMC Cell Biology"},{"key":"10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.actbio.2010.08.003","article-title":"Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cells","volume":"7","author":"Epple","year":"2011","journal-title":"Acta Biomaterialia"},{"key":"11","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.tiv.2009.06.001","article-title":"Ryu DY: Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells","volume":"23","author":"YiJ","year":"2009","journal-title":"Toxicology in Vitro"},{"key":"12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.toxlet.2009.09.014","article-title":"Effects of 45-nm silver nanoparticles on coronary endothelial cells and isolated rat aortic rings","volume":"191","author":"Carmen","year":"2009","journal-title":"Toxicology Lett"},{"key":"13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.toxlet.2008.04.015","article-title":"The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells","volume":"179","author":"Chueh","year":"2008","journal-title":"Toxicology Lett"},{"key":"14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1021\/am100840c","article-title":"Induction of apoptosis in cancer cells at low silver nanoparticle concentrations using chitosan nanocarrier","volume":"3","author":"Ghosh","year":"2011","journal-title":"ACS Appl Mater Interfaces"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Ahamed, Karns, Goodson, Rowe, Hussain, Schlager, Hong. DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells.Toxicology and Applied Pharmacology. 2008; 233:404\u2013410.","DOI":"10.1016\/j.taap.2008.09.015"},{"key":"16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.colsurfb.2009.04.025","article-title":"Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells","volume":"73","author":"Gurunathan","year":"2009","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"key":"17","first-page":"753","article-title":"Antitumor activity of silver nanoparticles in Dalton's lymphoma ascites tumor model","volume":"5","author":"Gurunathan","year":"2010","journal-title":"Inter J Nanomedicine"},{"key":"18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1021\/nn800596w","article-title":"Cytotoxicity and genotoxicity of silver nanoparticles in human cells","volume":"3","author":"Valiyaveettil","year":"2009","journal-title":"ACS Nano"},{"key":"19","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Mirimanoff","year":"2005","journal-title":"N Engl J Med"},{"key":"20","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1021\/j100214a025","article-title":"Adsorption and surface-enhanced Raman of dyes on silver and gold sols","volume":"86","author":"Meisel","year":"1982","journal-title":"J Phys Chem"},{"key":"21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.colsurfb.2013.01.027","article-title":"Biogenic silver nanoparticles for cancer treatment: an experimental report","volume":"106","author":"Sivanandhan","year":"2013","journal-title":"Colloids Surf B Biointerfaces"},{"key":"22","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1016\/j.biomaterials.2012.05.035","article-title":"TAT-modified nanosilver for combating multidrug-resistant cancer","volume":"33","author":"Huang","year":"2012","journal-title":"Biomaterials"},{"key":"23","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2217\/nnm.14.1","article-title":"Targeted delivery of silver nanoparticles and alisertib: in vitro and in vivo synergistic effect against glioblastoma","volume":"9","author":"Franchini","year":"2014","journal-title":"Nanomedicine (Lond)"},{"key":"24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/adhm.201300090","article-title":"Silver nanoparticles impregnated alginate-chitosan-blended nanocarrier induces apoptosis in human glioblastoma cells","volume":"3","author":"Ghosh","year":"2014","journal-title":"Adv Healthc Mater"},{"key":"25","doi-asserted-by":"crossref","first-page":"11829","DOI":"10.1039\/c3nr01351k","article-title":"Silver nanoparticles: a novel radiation sensitizer for glioma?","volume":"5","author":"Chen","year":"2013","journal-title":"Nanoscale"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13503","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T15:53:29Z","timestamp":1589126009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,22]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,1,31]]}},"alternative-id":["13503","27893419"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.13503","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,22]]}}}